A Non-Interventional Follow-Up to the VELOUR Study - Translational Research
NCT01754272 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1226
Last updated 2012-12-21
Summary
This is a follow-on study to the VELOUR trial (NCT00561470). The aim of this study is to acquire the archived colorectal cancer and metastasized tissue tumour blocks of patients who have participated in the VELOUR study.
These samples will be analysed to find proteins or markers which represent how an individual may be responding to treatment. The identification of these markers may help provide personalised and more effective treatment programs for patients with similar conditions in the future.
Conditions
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Principal Investigators
-
Sabine Tejpar, MD, PhD · KU Leuven
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
- Australia
- Austria
- Belgium
- Brazil
- Denmark
- Estonia
- Germany
- Greece
- Italy
- Netherlands
- Norway
- Romania
- Russia
- South Africa
- South Korea
- Spain
- Sweden
- United Kingdom
Study Locations
More Related Trials
-
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer
NCT01652196 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
NCT01858662 ·Status: TERMINATED ·Phase: PHASE2
-
Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers
NCT02384759 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer
NCT04810585 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer
NCT05678257 ·Status: TERMINATED ·Phase: PHASE2
-
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
NCT01858649 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen
NCT03279289 ·Status: COMPLETED ·Phase: PHASE2
-
Resection Observatory
NCT05178745 ·Status: COMPLETED
-
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
NCT03530267 ·Status: COMPLETED ·Phase: PHASE2
-
wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients
NCT01736904 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
NCT00006115 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Trial to Assess FOLFIRI+Aflibercept Efficacy in Patients With Oxaliplatin-pretreated Metastatic Colorectal Cancer With or Without ACE Polymorphisms
NCT02970916 ·Status: COMPLETED ·Phase: PHASE2
-
Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT01126866 ·Status: TERMINATED ·Phase: PHASE2
-
Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status
NCT04252456 ·Status: UNKNOWN ·Phase: NA
-
Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer
NCT00559741 ·Status: COMPLETED ·Phase: PHASE2
-
lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients
NCT04735900 ·Status: UNKNOWN ·Phase: NA
-
Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer
NCT00984048 ·Status: COMPLETED
-
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
NCT00075595 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
NCT00952029 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of IMC-11F8 in Participants With Colorectal Cancer
NCT00835185 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer
NCT00457691 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer
NCT03750786 ·Status: COMPLETED ·Phase: PHASE3
-
Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer
NCT01490996 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
NCT05217069 ·Status: COMPLETED ·Phase: PHASE2
-
Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies
NCT03043547 ·Status: COMPLETED ·Phase: PHASE2